Pursuant to the liquidity contract granted to NATIXIS the following elements were in the liquidity account as of December 31st, 2010:
- 5,632 NATUREX shares
- 103,376.35 euros
For information, the following elements appeared on the liquidity account as of June 30, 2010:
- 7,578 NATUREX shares
- 86,070.99 euros
Download our press releases and other publications on www.naturex.com
Naturex is listed on NYSE Euronext Paris since October 1996 – Compartment B.
Number of shares forming the capital: 6,410,931
ISIN: FR0000054694 (NRX) - Reuters: NATU.PA - Bloomberg: NRX:FP |
About Naturex
Naturex is the world leader in specialty plant-based natural ingredients.
The Group, organized around three strategic markets - Food&Beverage, Nutrition&Health and Personal Care - , manufactures and markets natural ingredients for food, nutraceutical, pharmaceutical and cosmetic industries.
Naturex, whose head office is based in Avignon (France), employs more than 950 persons and benefits from high performance industrial resources through 11 production sites in Europe (France, Italy, Spain, the United Kingdom and Switzerland), in Morocco, in the United States, in Brazil and in Australia. Moreover, the Group has a worldwide geographical presence through a dedicated sales network in 16 countries (France, Italy, Spain, the United Kingdom, Belgium, Germany, Switzerland, Russia, U.A.E, Thailand, Singapore, Japan, China, Australia, the United States, Australia).
Naturex’s sound performance is linked to the fast-growing demand for natural ingredients and its capacity to provide manufacturers customized solutions with the means to meet the requirements of their end consumers.
Its strength lies in its ability to position itself on specific products which constitute niche markets.
Contacts Naturex
Jacques Dikansky President and CEO Tél : +33 (0)4 90 23 96 89 naturex@naturex.com Carole Alexandre Investor Relations Tél : +33 (0)4 90 23 78 28 c.alexandre@naturex.com |
Thierry Lambert Vice-President and CFO Tél : +33 (0)4 90 23 96 89 t.lambert@naturex.com |
Contacts Actus
Anne Catherine Bonjour Press Relations Tél : +33 (0)1 53 67 36 93 acbonjour@actus.fr |
Jérôme Fabreguettes-Leib Investor Relations Tél : +33 (0)1 77 35 04 36 jfl@actus.fr |